AlphaMaven AlphaMaven

Lionsgate Studios stock gets Buy rating reaffirmed at Benchmark By Investing.com - Investing.com Canada

Reported by Cavesting ·Investing
Jul 16, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Benchmark initiated and has repeatedly reaffirmed a Buy rating on Lionsgate Studios Corp (NASDAQ: LION), with price targets ranging from $8.50 to $17.00 across multiple rating periods, reflecting analyst confidence in the company's strategic positioning.
  • • Lionsgate Studios stock currently trades at approximately $13.47–$14.09, positioning it near or below consensus analyst price targets, with the highest target of $20 issued by Baird on June 17, 2026, implying meaningful upside potential.
  • • Benchmark's Buy rating rationale is anchored in the company's "promising film slate," suggesting upcoming theatrical releases and content projects form the foundation of positive analyst sentiment.
  • • Consensus price target across 14 analysts stands at $13.05, indicating relatively tight clustering around current trading levels and suggesting modest near-term upside from the consensus view.
  • • The stock has demonstrated volatility, with historical trading range from $5.65 to $16.69 USD, and carries a negative P/E multiple of -19.46, indicating the company is not yet profitable on a GAAP earnings basis.
Summary
Benchmark has maintained a Buy rating on Lionsgate Studios Corp (NASDAQ: LION) with multiple price target updates reflecting evolving analyst views on the entertainment studio's fundamental prospects. The analyst firm initiated coverage with an $8.50 price target, subsequently raising it to $11.00, then to $15.00, and most recently to $17.00, demonstrating increasing conviction in the investment thesis over successive review periods. The Buy rating has been consistently reiterated across these upgrades, signaling sustained confidence.

The primary driver cited by Benchmark for its constructive view is Lionsgate's "promising film slate," indicating that near-term and medium-term theatrical releases represent material upside catalysts. For entertainment studios, a robust content pipeline is typically viewed as a proxy for revenue visibility and market share potential, particularly in a post-pandemic period marked by theatrical box office stabilization and streaming competition.

As of mid-July 2026, Lionsgate stock trades in the $13.47–$14.09 range, placing shares near the consensus price target of $13.05 derived from 14 analyst ratings. However, the highest target of $20 issued by Baird on June 17, 2026, suggests meaningful upside potential for investors with conviction in the film slate thesis. The company carries a market capitalization of approximately $4.06 billion and trades at a negative P/E multiple of -19.46, reflecting ongoing losses on a GAAP basis and indicating the market is pricing in a path to future profitability rather than current earnings power.

The stock's historical trading range from $5.65 to $16.69 USD underscores volatility typical of entertainment sector equities, which are highly dependent on film performance, release calendars, and consumer sentiment. For institutional investors, the gap between consensus pricing and the high-end Baird target of $20 presents a risk-reward asymmetry that may warrant tactical positioning, contingent on content portfolio assessment and theatrical market conditions.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

2 outlets

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Cavesting Lionsgate Studios stock gets Buy rating reaffirmed at Benchmark By Investing.com - Investing.com Canada Investing Lionsgate Studios stock gets Buy rating reaffirmed at Benchmark